Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center-Reference-Cited by-同舟云学术

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center

Published:2018-02-22 Issue:10 Volume:124 Page:2134-2141
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ciurea Stefan O.¹^ORCID,Labopin Myriam²³,Socie Gerard⁴,Volin Liisa⁵,Passweg Jakob⁶,Chevallier Patrice⁷,Beelen Dietrich⁸,Milpied Noel⁹,Blaise Didier¹⁰,Cornelissen Jan J.¹¹,Fegueux Nathalie¹²,Polge Emmanuelle²³,Kongtim Piyanuch¹,Rondon Gabriela¹,Esteve Jordi³,Mohty Mohamad¹³,Savani Bipin N.²¹⁴^ORCID,Champlin Richard E.¹,Nagler Arnon²¹⁵

Affiliation:

1. Department of Stem Cell Transplant and Cellular Therapy; The University of Texas MD Anderson Cancer Center; Texas

2. Acute Leukemia Working Party, European Society for Blood and Marrow Transplantation; Paris Study Office/European Center for Biostatistical and Epidemiological Evaluation in Hematopoietic Cell Therapy; Paris France

3. Institute of Hematology and Oncology, Department of Hematology, Hospital Clinic, August Pi I Sunyer Institute for Biomedical Investigation (IDIBAPS); University of Barcelona; Barcelona Spain

4. Department of Hematology; St. Louis Hospital; Paris France

5. Department of Medicine; Helsinki University Central Hospital; Helsinki Finland

6. Department of Hematology; University Hospital Basel; Basel Switzerland

7. Department of Hematology; Hotel-Dieu University Hospital Center; Nantes France

8. Department of Bone Marrow Transplantation; University Hospital, Essen; Essen Germany

9. Department of Hematology and Cellular Therapy; Bordeaux University Hospital Center, Haut-Leveque Hospital; Pessac France

10. Transplantation and Cellular Therapy Program, Marseille Center for Oncology Research; Paoli Calmettes Institute; Marseille France

11. Department of Hematology, Erasmus Medical Center Cancer Institute; University Medical Center Rotterdam; Rotterdam The Netherlands

12. Department of Clinical Hematology; Lapeyronie University Hospital Center; Montpellier France

13. Hematology and Cellular Therapy Department, Saint-Antoine Hospital; Pierre and Marie Curie University; Paris France

14. Long-Term Transplantation Clinic; Vanderbilt University Medical Center; Nashville Tennessee

15. Hematology Division, Chaim Sheba Medical Center, Tel Hashomer; Tel Aviv University; Tel Aviv Israel

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.31311/fullpdf

Reference19 articles.

1. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study;Slovak;Blood.,2000

2. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials;Grimwade;Blood.,2010

3. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia-analysis of 848 patients;Visani;Leukemia.,2001

4. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461);Byrd;Blood.,2002

5. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Dohner;Blood.,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Place de l’allogreffe dans les leucémies aiguës myéloblastiques et syndromes myélodysplasiques de très haut risque (SFGM-TC);Bulletin du Cancer;2024-09

2. Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics;International Journal of Molecular Sciences;2024-04-11

3. A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome;Bone Marrow Transplantation;2024-03-27

4. How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia;Bone Marrow Transplantation;2024-01-11

5. Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party;American Journal of Hematology;2024-01-02